Publications and Presentations
Invited extramural lectures and presentations
Local
2013 Insulin Resistance in Hospitalized Patients with Diabetes
Division of Endocrinology Grand Rounds
University of Colorado, School of Medicine, Aurora, CO
2015 The Ups and Downs of Steroids and Diabetes
Blood Cancer and Bone Marrow Transplant Grand Rounds
University of Colorado, School of Medicine, Aurora, CO
2021 COVID-19, hyperglycemia and diabetes - What’s the connection?
Division of Endocrinology Grand Rounds
University of Colorado, School of Medicine, Aurora, CO
Regional
2013 Steroid Induced Diabetes in the Hematologic Malignant Patient Population
Colorado Oncology Nursing Society: 2013 Fall Conference
Denver, CO
2015 Outpatient Management of Diabetes: From Metformin to Inhaled Insulin
UCH Advanced Practice Provider Conference:
Improving Care from Office to Bedside
Denver, CO
2016 Inpatient Diabetes in Special Populations
2016 Central States Private Education Network Nutrition Support Conference
Denver, CO
2017 Best Practice in Pharmacotherapeutics for Primary Care
Diabetes Management and New Medications
University of Colorado College of Nursing
Skaggs School of Pharmacy
Denver, CO
2018 Advanced Practice: Leading Healthcare into the Future
Invited Presenter
“Writing as Part of a Team”
University of Colorado Hospital Advanced Practice Provider Conference
Aurora, CO
2018 Advanced Practice: Leading Healthcare into the Future
Invited Presenter
“Honing Your Preceptor Skills – Workshop”
University of Colorado Hospital Advanced Practice Provider Conference
Aurora, CO
2020 Best Practice Pharmacotherapeutics - 2020
Continuous Glucose Monitoring Systems
CU College of Nursing
Denver, CO
2020 ECHO (Extension for Community Health Outcomes) Colorado
Invited Presenter
“Challenging Endocrine Cases”
Webinar
Aurora, CO
National
2013 Managing Diabetes: More than Just Sugar
Kindred Healthcare Clinical Impact Symposium – 2013
Louisville, KY
2018 10th Annual EBP/Research Conference
Evidence for Practice; Origins and New Directions
Podium Presentation: “Improving blood glucose control in non-critically ill hospitalized adults by reducing repeat hyperglycemic episodes.”
Oschner Health System
New Orleans, LA
2019 National Association of Clinical Nurse Specialist Annual Conference
Podium Presentation on Inpatient Glucose Management
Orlando, FL
2020 National Association of Clinical Nurse Specialist Annual Conference
Podium Presentation on Advanced Practice Preceptor Develop
(Conference Canceled)
2020 National Association of Clinical Nurse Specialist
Webinar on Inpatient Glucose Management
Aurora, CO
International
2018 American Diabetes Association 78th Annual Scientific Sessions
Invited Podium Presentation
“Building an Inpatient Glucose Management Team”
Orlando, FL
Peer-Reviewed Journals
1. McDermott M, Haugen B, Lezotte D, Seggelke S, & Ridgway EC. Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients. Thyroid. 2001; 11(8): 757-764.
2. Seggelke SA, Gibbs J, Draznin B. Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. Journal of Hospital Medicine. 2011; 6(3): 175-176.
3. Seggelke SA. Hitting the target for inpatient diabetes management. Nurse Practitioner. 2011; 36(5): 24 – 31.
4. Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutrition in Clinical Practice. 2011; 26(6):714-7.
5. Hsai, E, Seggelke S, Gibbs, J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. Journal of Clinical Endocrinology and Metabolism. 2012; 97(9): 3132-3137.
6. Rasouli N, Seggelke S, Gibbs J, Hawkins RM, Casciano ML, Cohlmia E, Taylor-Cousar J, Wang C, Pereira R, Hsai E, Draznin B. Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions. Journal of Diabetes Science and Technology. 2012; 6(5): 1038-1044.
7. Seggelke S and Everhart B. Managing glucose levels in hospitalized patients. American Nurse Today. 2012; 7(9): 27-31.
8. Seggelke S and Everhart B. Managing of type 2 diabetes. The Nurse Practitioner. 2013; 38(6): 13-16.
9. Seggelke SA. Severe hypoglycemia leads to a seizure. American Nurse Today. 2013; 8(7): 11
10. Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Low Wang C, and Draznin B. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes. Endocrine Practice. 2014; 20(6): 536 – 539.
11. Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hospital Practice.2014; 42(1):46-51.
12. Seggelke S. Hypoglycemia: Fear of the low. American Nurse Today. 2014; 9 (8).
13. Draznin B, Wang Y, Seggelke S, Hawkins RM, Gibbs J, Bridenstine M, Rasouli N, Wang CL. Glycemic control and outcomes of hospitalization in non-critically ill patients with Type 2 diabetes admitted with cardiac problems or infections. Endocrine Practice. 2014; 20(6):1-14.
14. Seggelke S. Supplemental nutrition in hospitalized patients with diabetes. American Nurse Today. 2014; 9 (12)
15. Draznin D, Wang Y, Seggelke S, et al. Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections. Endocrine Practice. 2014; (412): 1303 – 1308.
16. Wang YJ, Seggelke S, Hawkins RM, Gibbs J, Lindsay M, Hazlett I, Low Wang CC, Rasouli N, Young KA, Draznin B. Impact of glucose management team on outcomes of hospitalization in patients with type 2 diabetes admitted to the medical service. Endocrine Practice. 2016; 22(12):1401-1405.
17. Seggelke SA, Lindsay MC, Hazlett I, Sanagorski R, Eckel RH, Low Wang CC. Cardiovascular safety of antidiabetic drugs in the hospital setting. Curr Diab Rep. 2017; 17(8):64.
18. Seggelke SA, Ingram CC, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clinical Diabetes. 2021.
Book Chapter
1. Seggelke SA and Draznin B. Inpatient management of diabetes and hyperglycemia. In: McDermott MT (Ed). Endocrine Secrets, 6th Edition. Philadelphia, PA, Saunders, 2013, 28-38.
2. Seggelke SA. Factitious Hypoglycemia in a Type 2 Diabetic Patient. In Diabetes Case Studies. Draznin B, Low Wang CC, Rubin DJ, Eds. Alexandria, VA, American Diabetes Association, 2015, p. 314-316.
3. Seggelke S, Draznin B. Therapeutic Hypothermia and Severe Insulin Resistance in Patients with Diabetes and Cardiac Arrest. In Diabetes Case Studies. Draznin B, Low Wang CC, Rubin DJ, Eds. Alexandria, VA, American Diabetes Association, 2015, p. 211-213.
4. Draznin B, Dungan K, Seggelke S. Insulin resistance in patients treated with therapeutic hypothermia and in patients with severe burns. In Managing Diabetes and Hyperglycemia in the Hospital Setting: A clinician’s Guide. Draznin B, Ed. Alexandria, VA, American Diabetes Association, 2016, p. 192-197.
5. Seggelke S: Contributing Reviewer – Inpatient Diabetes Education. In Low Wang CC, Shah A, (Eds) Medical Management of Type 1 Diabetes, 7th edition. Alexandria, VA, American Diabetes Association, 2017, 45 – 58.
6. Seggelke S and Hawkins, RM. Inpatient management of diabetes and hyperglycemia. In: McDermott MT (Ed). Endocrine Secrets, 7th Edition. St. Louis, MO, Elsevier, 2020, 61 – 66.
7. Seggelke, S and Wren, MJ. Endocrine System. In Duffy M, Dresser S, Fulton JS (Eds) Adult-Gerontology Clinical Nurse Specialist Examination Review Book, 2nd Edition, 2020, 115 – 130.
Posters
1. Baldwin D, Kinnare K, Draznin B, Seggelke SA, Krinsley J, Gandhi S, Bhalani V, Braithwite S, Srinivasa C, Heintz K, Dungan K, Berhard J, AEdgren A, Diaz J, Aronson M, Barnosky A, Emanuele M. Insulin treatment of hyperglycemia in hospitalized patients receiving total parenteral nutrition (TPN). Poster session presented at: Clinical diabetes/Therapeutics. American Diabetes Association 72nd Scientific Session; 2012 June 8-12; Philadelphia, PA.
2. Wang CC, Seggelke S, Hawkins M, Cohlmia E, Gibbs J, Rasouli N, Draznin B. Transitional care clinic for patients with diabetes may prevent re-hospitalizations. Poster session presented at: Healthcare delivery. American Diabetes Association 73rd Scientific Session; 2013 June 21-15; Chicago, IL.
3. Draznin B, Wang Y, Seggelke SA, Hawkins M, Gibbs J, Rasouli N, Wang C. Optimal glycemic control improves clinical outcomes in patients with type 2 diabetes. Poster session presented at: Healthcare delivery. American Diabetes Association 73rd Scientific Session; 2013 June 21-15; Chicago, IL.
4. Seggelke S, Hawkins M, Gibbs J, Cohlmia E, Rasouli N, Wang C, Draznin B. Effects of glargine insulin delivery method (pen-device vs. vial-syringes) on glycemic control and patient preferences. Poster session presented at: Clinical therapeutics. American Diabetes Association 73rd Scientific Session; 2013 June 21-15; Chicago, IL.
5. Seggelke, S. Improving blood glucose control in non-critically ill hospitalized adults by reducing repeat hyperglycemic episodes. Poster presentation at: Advanced Practice: Leading Healthcare into the Future; 2018 Sept 2018; Aurora, CO
6. Seggelke, S. Advanced Practice Provider Preceptor Education: Training the Future Workforce. Poster presentation at: Advanced Practice: Leading Healthcare into the Future; Sept 2019; Aurora, CO
Other
1. Seggelke S. Endocrinology Section for the AACN ACCNS-AG Certification Review Section, January 2014 - On-line recording.
